Testicular Cancer Monitor Profile
| Testicular Cancer Monitor Profile | | | |
| Number | | 485151 |
| CPT | | 82105; 84702 |
| Test Includes | | Alpha-fetoprotein (AFP), serial monitor report; β-hCG, serial monitor report |
| Special Instructions | | The account must submit the patient's Social Security number to monitor. Values obtained with different assay methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy. |
| Specimen | | Serum |
| Volume | | 3 mL |
| Minimum Volume | | 1 mL |
| Container | | Red-top tube or gel-barrier tube |
| Collection | | If a red-top tube is used, transfer separated serum to a plastic transport tube. |
| Storage Instructions | | Refrigerate |
| Causes for Rejection | | Gross hemolysis; whole blood specimen |
| Use | | Monitor the course of testicular cancer, patient response to treatment, and disease recurrence |
| Limitations | | This profile should not be used as a diagnostic or screening test for cancer. The β-hCG procedure may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients. |
| Methodology | | See individual tests. |
|